Zentek Court Dismisses Eveleigh's Over $6 Million Claims
Zentek announces that the Ontario Superior Court of Justice has issued its Reasons for Judgment dated March 12, 2026, in the companion actions Eveleigh et al. v. Zenyatta; Zentek v. Eveleigh et al., 2026 ONSC 1510. The litigation arose following the removal of Aubrey Eveleigh, the Company's founder and former President and CEO, by shareholders at a special meeting held on May 11, 2018. The two companion actions were tried together before Justice Osborne of the Ontario Superior Court of Justice. The Court dismissed substantially all claims advanced by Mr. Eveleigh and his consulting firm, Eveleigh Geological Consulting Inc. Original claims, as filed, exceeded $6 million. At trial, the claims were refined and the Court denied all remaining monetary claims, specifically: A Success Fee claim of $282,500 - denied on the basis that the pre-feasibility study required to trigger the payment obligation was never commenced; Severance claims totaling $1,350,000 under the President's Agreement and related Memorandum of Agreement - found to be void and unenforceable as a result of breaches of fiduciary duty; Unpaid wages of $51,748.82 - denied; Defamation damages of $75,000 - denied, with the Court finding the relevant statements were factually accurate; and Indemnification claims of approximately $194,000 in costs and disbursements - denied. With respect to Zentek's claim for cancellation of 4.5 million founder shares and disgorgement of profits, the Court found that the shares had been properly issued and that there was no basis to set aside the issuance.
Trade with 70% Backtested Accuracy
Analyst Views on ZTEK
About ZTEK
About the author


Alphabet Inc. Stock Surge: Shares of Alphabet Inc. rose 5.8% in pre-market trading after a U.S. judge ruled that Google does not need to divest its Android operating system or sell Google Chrome in the ongoing online search monopoly case.
Pre-Market Stock Movements: Several stocks experienced significant changes in pre-market trading, with Solidion Technology, Inc. gaining 130.1%, while SmartKem, Inc. saw a decline of 21.4% after a previous surge.
Oversold Stocks Opportunity: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies.
Zentek Ltd Performance: Zentek's stock has an RSI of 29.8, with a recent quarterly loss and a 33% decline over the past month, closing at $0.65.
Nano-X Imaging Ltd Update: Nano-X Imaging has an RSI of 27.5, reported a narrower-than-expected quarterly loss, and saw its stock drop 24% recently, closing at $3.89.
OmniAb Inc Developments: OmniAb's stock has an RSI of 26.7, announced a $30 million private placement, and experienced a 19% decline in the last five days, closing at $1.63.
CEO Contract Update: Zentek announced that it will not extend CEO Greg Fenton's consulting contract, which expires on March 31, 2026, and has initiated a search for his successor.
Stock Performance: Following the announcement, Zentek's stock price fell by 3.23% to $1.05 in after-hours trading.
Market Volatility and Stock Selection: The Canadian stock market has seen significant fluctuations, with the TSX hitting all-time highs despite earlier declines. Investors are advised to focus on stocks with strong financial fundamentals, including smaller companies often referred to as "penny stocks."
Company Highlights: Notable companies discussed include Galleon Gold Corp., Radius Gold Inc., and Zentek Ltd., all of which are in the pre-revenue stage but show potential for growth through exploration and innovative projects, despite facing financial challenges.
Zentek's Albany Graphite Test Results: Zentek has achieved a 99.9991% purity in graphite through a fluidized bed reactor process, which also allows for the recovery of rare earth elements (REEs) as by-products during thermal purification.
Future Plans and Applications: The company aims to further explore the REE potential of the Albany deposit and intends to develop battery-ready anode materials, cathode conductivity enhancers, and ultra-high purity graphite for nuclear applications.
Zentek Q1 2025 Results: Zentek (NASDAQ:ZTEK) reported a first-quarter earnings per share of -2 cents and revenue of $4.01 million.
Automated Earnings Reporting: InvestorPlace Earnings utilizes TradeSmith data to provide automated coverage of quarterly earnings, highlighting key financial metrics without human intervention.









